Allison Chunyk - Alpine Immune Sciences

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

POVETACICEPT, AN ENHANCED DUAL BAFF/APRIL ANTAGONIST, IN AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS (GN)

Harmeet Singh,Arvind Madan, Sreedhar Mandayarn,Hemant Kulkarni,Frank Cortazar,Sang-Woong Han,Sung Gyun Kim,Jonathan Barratt,Brad Rovin,Hong Zhang,Rupert Davies,Amanda Enstrom,Allison Chunyk,Heather Thomas', Jiahua Li,Stanford L. Peng, James Tumlinu

AMERICAN JOURNAL OF KIDNEY DISEASESno. 4 (2024): S122-S122

引用0浏览0引用

Initial Report of Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Autoimmune Cytopenias: the RUBY-4 Study

Catherine Broome,David J. Kuter,Keith R. McCrae,Rupert Davies,Amanda Enstrom,Allison Chunyk,Heather Thomas,Allison Naumovski,Steven R. Lentz

BLOOD (2023)

引用0浏览0引用

Upregulation of Both APRIL and BAFF in Systemic Lupus Erythematosus Suggests Non-Redundant Roles, Further Revealed by Dual Inhibition with Povetacicept (ALPN-303; TACI Vtd-Fc)

Tiffany Blair, Elizabeth Repash, Armand Bankhead, Amanda Enstrom,Lawrence Evans, Susan Debrot,Allison Chunyk,Sherri Mudri, Stanford Peng, Stacey Dillon

ARTHRITIS & RHEUMATOLOGY (2023): 4659-4661

引用0浏览0引用

42273 Phase 1 Study in Healthy Adults of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-303, a Dual BAFF/APRIL Antagonist for the Treatment of Autoimmune Blistering Diseases

Stacey R. Dillon,Rupert H. Davies,Jason D. Lickliter,Alina Smith,Mary C. Lessig,Lori Blanchfield,Russell J. Sanderson,Allison Chunyk,Amanda Enstrom,Hany Zayed,Stanford L. Peng

Journal of the American Academy of Dermatologyno. 3 (2023): AB74-AB74

引用0浏览0引用

S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES

Stacey R. Dillon,R. H. Davies,Jason D. Lickliter,Kristi Mclendon,Kristi L. Manjarrez,Alina Smith,Krystalyn E. Hudson,Lori Blanchfield,Russell J. Sanderson,Allison Chunyk,Tiffany C. Blair,Amanda Enstrom,Hany Zayed,Stanford L. Peng

HemaSphereno. S3 (2023): e3301055-e3301055

引用0浏览0引用

#4024 phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of povetacicept for autoimmune glomerulonephritides

Stacey Dilllon,Rupert Davies,Jason Lickliter,Kristi Mclendon,Kristi Manjarrez,Alina Smith,Lori Blanchfield,Russell Sanderson,Allison Chunyk,Amanda Enstrom,Tiffany Blair,Hany Zayed, Jiahua LI,Stanford Peng

Nephrology Dialysis Transplantationno. Supplement_1 (2023)

引用0浏览0引用

Phase 1 Study in Healthy Adults of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-303, a Dual BAFF/APRIL Antagonist for the Treatment of Autoimmune Glomerulonephritides (GN)

Stacey R. Dillon,Pille Harrison,Jason Lickliter,Kristi L. Manjarrez,Alina Smith,Mary C. Lessig,Russell J. Sanderson,Allison G. Chunyk,Katherine Lewis,Hany Zayed,Rupert H. Davies,Stanford Peng

Journal of the American Society of Nephrologyno. 11S (2022): 188-188

引用0浏览0引用

A Randomized Placebo-Controlled Phase 1 Study in Healthy Adult Volunteers of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN-303, a Potent Dual BAFF/APRIL Antagonist for the Treatment of Systemic Lupus Erythematosus and Other Autoantibody-Associated Diseases

Stacey Dillon,Pille Harrison,Jason Lickliter,Kristi Manjarrez,Alina Smith, Mary Lessig,Lori Blanchfield,Russell Sanderson,Allison Chunyk,Tiffany Blair,Amanda Enstrom,Martin Wolfson,Mark Rixon,Hany Zayed,Rupert Davies,Stanford Peng

ARTHRITIS & RHEUMATOLOGY (2022): 1953-1955

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn